Phylogenetic analysis and predicted functional effect of protein mutations of E6 and E7 HPV16 strains isolated in Indonesia

  • Dwi Wulandari Research Center for Biotechnology, Indonesian Institute of Sciences-LIPI, Bogor
  • Lisnawati Rachmadi Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital
  • Tjahjani M. Sudiro Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta
Keywords: cervical cancer, E6 & E7 gene, E6 & E7 proteins, HPV16 variant, phylogenetic, SNAP
Abstract viewed: 1980 times
PDF downloaded: 930 times


Background: E6 and E7 are oncoproteins of HPV16. Natural amino acid variation in HPV16 E6 can alter its carcinogenic potential. The aim of this study was to analyze phylogenetically E6 and E7 genes and proteins of HPV16 from Indonesia and predict the effects of single amino acid substitution on protein function. This analysis could be used to reduce time, effort, and research cost as initial screening in selection of protein or isolates to be tested in vitro or in vivo.

Methods: In this study, E6 and E7 gene sequences were obtained from 12 samples of Indonesian isolates, which were compared with HPV16R (prototype) and 6 standard isolates in the category of European (E), Asian (As), Asian-American (AA), African-1 (Af-1), African-2 (Af-2), and North American (NA) branch from Genbank. Bioedit v.7.0.0 was used to analyze the composition and substitution of single amino acids. Phylogenetic analysis of E6 and E7 genes and proteins was performed using Clustal X (1.81) and NJPLOT softwares. Effects of single amino acid substitutions on protein function of E6 and E7 were analysed by SNAP.

Results: Java variants and isolate ui66* belonged to European branch, while the others belonged to Asian and African branches. Twelve changes of amino acids were found in E6 and one in E7 proteins. SNAP analysis showed two non neutral mutations, i.e. R10I and C63G in E6 proteins. R10I mutations were found in Af-2 genotype (AF472509) and Indonesian isolates (Af2*), while C63G mutation was found only in Af2*.

Conclusion: E6 proteins of HPV16 variants were more variable than E7. SNAP analysis showed that only E6 protein of African-2 branch had functional differences compared to HPV16R.

Author Biographies

Dwi Wulandari, Research Center for Biotechnology, Indonesian Institute of Sciences-LIPI, Bogor
Research center for biotechnology
Lisnawati Rachmadi, Department of Anatomical Pathology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital

Tjahjani M. Sudiro, Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta


  1. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, Bosch FX, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol. 1997;71(3):2463–72.

  2. Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98(10):1505–11.

  3. Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, Desalle R, et al. Sequence imputation of HPV16 genomes for genetic association studies. PLoS One. 2011;6(6):e21375.

  4. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27.

  5. Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401(1):70–9.

  6. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518–27.

  7. [internet]. Spain: ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), [update 2014 Dec 18]. Available from:

  8. Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG. Human papillomavirus type 16 DNA sequence. Virology. 1985;145(1):181–5.

  9. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002;89(2):229–40.

  10. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69(12):7743–53.

  11. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, Segondy M, et al. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PloS One. 2011;6(5):e20183.

  12. Burk RD, Chen Z, Harari A, Smith BC, Kocjan BJ, Maver PJ, et al. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(3):113–23.

  13. Cornet I, Gheit T, Franceschi S, Vignat J, Burk RD, Sylla BS, et al. Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol. 2012.86(12):6855–61.

  14. de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, Vrede MA, et al. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol. 2004;94(2):488–94.

  15. Daf S, Jena L, Kumar S. Comparative phylogenetic analysis of E6 and E7 proteins of different 42 strains of HPV. JK Science. 2010;12(1):6–10.

  16. Pientong C, Wongwarissara P, Ekalaksananan T, Swangphon P, Kleebkaow P, Kongyingyoes B, et al. Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol J. 2013;10(30):1–9.

  17. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007;35(11):3823–35.

  18. Katsonis P, Koire A, Wilson SJ, Hsu TK, Lua RC, Wilkins AD, et al. Single nucleotide variations: biological impact and theoretical interpretation. Protein Sci. 2014;23(12):1650–66.

  19. Adeel MM, Qasim M, Ashfaq UA, Masoud MS, ur Rehman M, ul Qamar MT, et al. Modelling and simulation of mutant alleles of breast cancer metastasis suppressor 1 (BRMS1) gene. Bioinformation. 2014;10(7):454–9.

  20. Lurchachaiwong W, Junyangdikul P, Payungporn S, Chansaenroj J, Sampathanukul P, Tresukosol D, et al. Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings. Virus Genes. 2009;39(1):30–8.

  21. Bioedit software. (internet).available from

  22. ClustalX software. (internet).available from

  23. NJPLOT software. (internet). available from

  24. Zhang S, Wang T. Phylogenetic analysis of protein sequences based on conditional LZ complexity. MATCH Commun. Math. Comput. Chem. 2010;63:701–16.

  25. Oppedoes F. Phylogenetic analysis using protein sequences In: Salemi M, Vandamme A-M. The Phylogenetic Handbook: A practical approach to DNA and protein phylogeny. Cambridge: Cambridge University Press. 2003. p. 210–43.

  26. Giannoudis A, Herrington CS. Human papillomavirus variants and squamous neolasia of the cervix. J Pathol. 2001;193(3):295–302<::AID-PATH809>3.3.CO;2-3

  27. Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, Sharma R, et al. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol. 2008;46(3):1060–6.

  28. Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P. The frequency of HLA alleles in a population of Inuit women of northern Quebec. Int J Circumpolar Health. 2013;5(72):1–4.

  29. Berumen J, Ordo-ez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst. 2001;93(17):1325–30.

  30. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93(4):315–8.

  31. Xi LF, Koutsky LA, Hildesheim A, Galloway DA, Wheeler CM, Winer RL, et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007;16(1):4–10.

  32. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs16 and 18. Int J Cancer. 2007;120(8):1763–8.

  33. Freitas LB, Chen Z, Muqui EF, Boldrini NA, Miranda AE, Spano LC, et al. Human papillomavirus 16 non-European variants are preferentially associated with high-grade cervical lesions. 2014. PLoS One. 2014;9(7):e100746.

  34. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, Jackman A, et al. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 2006;350(1):216–27.

How to Cite
Wulandari D, Rachmadi L, Sudiro TM. Phylogenetic analysis and predicted functional effect of protein mutations of E6 and E7 HPV16 strains isolated in Indonesia. Med J Indones [Internet]. 2015Dec.31 [cited 2024Apr.19];24(4):197-05. Available from:
Basic Medical Research